Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate 2018-12-19 08:00
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab) 2018-12-17 21:30
lululab Named as CES 2019 Innovation Awards Honoree 2018-12-17 21:00
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program 2018-12-17 19:10
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman 2018-12-14 21:00
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints 2018-12-13 08:00
Cathay Industrial Biotech Invests an Additional USD 500 Million to Expand its Production Capacity for New Bio-based Materials 2018-12-11 20:45
GenEdit Closes $8.5 million Series Seed Financing 2018-12-11 13:17
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services 2018-12-10 16:00
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:12
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs 2018-11-29 15:40
An Animal Test Demonstrated that Lactic Acid Bacteria Isolated from Kimchi Enhance Immunity 2018-11-28 22:00
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies 2018-11-28 19:44
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan 2018-11-28 08:00
Lactic Acid Bacteria in Kimchi Reduce Cholesterol in Blood 2018-11-26 22:00
Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer 2018-11-26 21:30
WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai 2018-11-22 14:31
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis 2018-11-19 07:00
World Institute of Kimchi: Function-enhanced kimchi inhibits growth of cancer cells 2018-11-16 22:00
WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou 2018-11-16 18:00
1 138 139 140 141 142 227